EDIT | Editas
Category: Pharmaceutical company
Next ER: August 3, 2022 Before Market Opens
About the Company
Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPRâCas9 gene editing technology. The company went public on 2 Feb 2016.
NASDAQ - Nasdaq Stock Market
More profiles and info about the company
This company doesn't provide a dividend.
Talk about Editas below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
Buy on Amazon
Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.